Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles.

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

2013 • 5,819 citations

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses

1984 • 696 citations

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

1988 • 626 citations

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160

1990 • 593 citations

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

1988 • 540 citations

The Biochemistry, Biology, and Role of Interleukin 2 in the Induction of Cytotoxic T Cell and Antibody-Forming B Cell Responses

1982 • 524 citations

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.

1988 • 514 citations

Immunological adjuvants: a role for liposomes

1990 • 468 citations

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1988 • 417 citations

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

1987 • 335 citations

Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins

1987 • 301 citations

A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus Infection

1991 • 248 citations

Infectious Mutants of HTLV-III with Changes in the 3′ Region and Markedly Reduced Cytopathic Effects

1986 • 236 citations

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

1989 • 225 citations

A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS

1988 • 183 citations

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection

1987 • 177 citations

The expression of hybrid HIV:Ty virus-like particles in yeast

1987 • 163 citations

Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans

1988 • 146 citations

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.

1987 • 138 citations

PREVALENCE, INCIDENCE, AND PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN HOMOSEXUAL AND BISEXUAL MEN IN HEPATITIS B VACCINE TRIALS, 1978–1988

1989 • 126 citations

Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.

1989 • 124 citations

Immunogenicity of peptide fusions to hepatitis B virus core antigen.

1989 • 113 citations

Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys.

1990 • 81 citations

Immunological properties of hepatitis B core antigen fusion proteins.

1990 • 67 citations

Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant

1991 • 59 citations

HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.

1990 • 45 citations

Ty: A retroelement moving forward

1988 • 41 citations

Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies.

1991 • 25 citations